ShareChat

The US Market closed higher on Friday as investors shifted their focus to next week, with third-quarter earnings season set to start and inflation data expected, which could shed light on Federal Reserve's next policy decision. The Dow Jones Industrial Average up 0.83%, while the S&P 500 and Nasdaq Composite were up 0.59% and 0.64% respectively. Other key markets ended higher. European stocks closed as follows: the FTSE100 (+1.06%), the Dax 30 (+1.13%), CAC 40 (+0.95%) and the STOXX (+0.76%).

Stocks rally despite higher yields as oil slips lower Global US stocks extended their gains overnight, with the S&P 500 up 0.8%, the Nasdaq up 1.2% and the Russell 2000 up 0.9%. Every sector except real estate rose. Materials and energy led, helped by a roughly 6% jump in steel stocks after US anti-dumping protections were kept in place. Energy gained about 1% even though oil fell 2.5%.

Vista Group International Limited (NZX & ASX: VGL) advises that the attached presentation will be delivered at the NZX Tech Investor Day being held at the New Zealand International Convention Centre later today. For further information please contact: Matt Thompson Chief Financial Officer Vista Group International Limited Contact: +64 9 984 4570 About Vista Group Vista Group International Limited is a global leader in providing technology solutions to the international film industry.

AFT reports double digit revenue growth in 1H FY27 and R&D progress HIGHLIGHTS - On track to reach $300 million FY27 revenue target with all divisions showing double digit revenue growth in 1H FY27 - FY27 operating profit guidance affirmed at $28 million to $32 million - Maxigesic IV out licensed in Japan and the Philippines - AFT’s fridge-free medicines R&D partner, StablePharma gains further validation for its technology - Achieved our third US FDA approval for a patented product with...

Kiwi insurer Tower (NZX/ASX: TWR) today revised its FY26 underlying net profit after tax (underlying NPAT) guidance for the year to 30 September 2026. Based on preliminary, unaudited results, Tower now expects FY26 full-year underlying NPAT to be between $69m and $79m, compared with its previous guidance range of $55m to $65m. The uplift reflects Tower’s large event allowance of $45m not being fully utilised during the year.

The US Market closed lower on Thursday as crude prices surged on a spike in Middle East tensions and a cut in US output that fed inflation and rate-hike fears, while semiconductor stocks slumped. The Dow Jones Industrial Average up 0.05%, while the S&P 500 and Nasdaq Composite were down 0.53% and 1.31% respectively. Other key markets ended higher. European stocks closed as follows: the FTSE100 (-0.16%), the Dax 30 (-1.18%), CAC 40 (-0.51%) and the STOXX (-0.87%).

The Nasdaq closed higher on Tuesday as crude prices steadied and US Treasury yields eased, offering some reprieve from concerns that have preoccupied investors in recent weeks, and allowing markets to turn their attention to the approaching third-quarter reporting season. The Dow Jones Industrial Average up 0.53%, while the S&P 500 and Nasdaq Composite were up 0.60% and 0.45% respectively. Other key markets ended higher.

CDC’s independent valuation was broadly flat with a mid-point valuation of A$18.5 billion at 30 September 2026. Continued progress in customer contracting and the development of CDC’s capacity pipeline was offset by the macroeconomic impact of a material increase in the forward yield curve, resulting in higher assumed interest costs over the forecast period.

The US Market closed lower on Wednesday as long-dated US Treasury yields resumed their climb, reviving fears over inflation and mounting debt. The Dow Jones Industrial Average down 0.67%, while the S&P 500 and Nasdaq Composite were down 0.23% and 0.26% respectively. Other key markets ended higher. European stocks closed as follows: the FTSE100 (-0.79%), the Dax 30 (-1.35%), CAC 40 (-1.22%) and the STOXX (-1.47%). In Asia, the Hang Seng and Shanghai indices closed higher.

TruScreen Group Limited (NZX/ASX: TRU), (“TruScreen” or “the Company”), a global leader in AI-enabled cervical cancer screening, advises that for personal reasons, Martin Dillon, Chief Executive Officer (CEO), has resigned from the Company with effect from 31 October 2026. Tony Ho, Non-Executive Independent Chairman, will assume the responsibilities of Executive chairman and Interim CEO while the Company undertakes a recruitment process for a new Chief Executive Officer.